Document Detail


The many faces of type 2 diabetes.
MedLine Citation:
PMID:  20675986     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: This report illustrates the treatment progression of a patient with rapidly decompensating type 2 diabetes. METHODS: The patient had to transition to insulin therapy within 2 years of her initial diagnosis, following only a brief period of glycemic control with diet management, weight loss, and oral agents. This relatively rapid progression to insulin requirement is occasionally seen in adults with typical type 2 diabetes that may classify as a number of different subtypes of diabetes. RESULTS: The case presented demonstrates how a simple stepwise approach to dose titration with basal insulin helped a patient with severe depletion of endogenous insulin achieve initial glycemic control, and how the addition of prandial insulin helped control her mealtime glycemic excursions. CONCLUSION: The use of basal-prandial insulin therapy is an effective option for patients with rapidly decompensating type 2 diabetes to achieve their glycemic goals without delays and to minimize associated morbidities.
Authors:
Thomas Flood
Related Documents :
8554246 - Effects of intensive diabetes therapy on neuropsychological function in adults in the d...
6765226 - Reversible acute pulmonary edema due to uncontrolled hyperglycemia in diabetic individu...
15317436 - Insulin therapy for type 2 diabetes: rescue, augmentation, and replacement of beta-cell...
11394726 - Matching treatment to pathophysiology in type 2 diabetes.
9423296 - Comparative chemical and biological studies of the alkaloidal content of lygos species ...
21222056 - Glycemic index and glycemic load of carbohydrates in the diabetes diet.
Publication Detail:
Type:  Case Reports; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Postgraduate medicine     Volume:  122     ISSN:  1941-9260     ISO Abbreviation:  Postgrad Med     Publication Date:  2010 Jul 
Date Detail:
Created Date:  2010-08-02     Completed Date:  2010-09-14     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0401147     Medline TA:  Postgrad Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  218-23     Citation Subset:  AIM; IM    
Affiliation:
Georgia Center for Diabetes, Atlanta, GA 30342, USA. sugardoctor@mindspring.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Diabetes Mellitus, Type 2 / diagnosis,  drug therapy*
Female
Humans
Hypoglycemic Agents / therapeutic use*
Insulin / analogs & derivatives*,  therapeutic use
Middle Aged
Chemical
Reg. No./Substance:
0/Hypoglycemic Agents; 0/glargine; 11061-68-0/Insulin; 207748-29-6/insulin glulisine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Necrotizing fasciitis in a woman with a diabetic foot infection and peripheral neuropathy.
Next Document:  Puzzles in practice.